FindTrial
Sign In

Clinical characteristics and treatment of novel coronavirus pneumonia (COVID-19)

Clinical characteristics and treatment of COVID-19

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030796
Enrollment
Unknown
Registered
2020-03-15
Start date
2020-01-29
Completion date
Unknown
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:Nil

Sponsors

The Second Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who meet the diagnostic criteria for confirmed cases of pneumonia in the diagnosis and treatment program for novel coronavirus infection (trial seventh edition) issued by the national health commission on March 3, 2020

Exclusion criteria

Exclusion criteria: Non-definitively diagnosed cases

Design outcomes

Primary

MeasureTime frame
mortality;effective rate;—

Secondary

MeasureTime frame
positive rate;—

Contacts

Public ContactYuan Yadong

The Second Hospital of Hebei Medical University

yuanyd1108@163.com+86 15833119392

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026